{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Sorafenib_Tosylate",
  "nciThesaurus": {
    "casRegistry": "475207-59-1",
    "chebiId": "CHEBI:50928",
    "chemicalFormula": "C21H16ClF3N4O3.C7H8O3S",
    "definition": "The tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis.",
    "fdaUniiCode": "5T62Q3B36J",
    "identifier": "C2194",
    "preferredName": "Sorafenib Tosylate",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C129825",
      "C159199",
      "C2336",
      "C93259"
    ],
    "synonyms": [
      "4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic Acid Methyamide-4-methylbenzenesulfonate Tosylate",
      "BAY 43-9006 Tosylate",
      "BAY 54-9085",
      "Nexavar",
      "SORAFENIB TOSYLATE",
      "Sorafenib Tosylate",
      "sorafenib",
      "sorafenib tosylate"
    ]
  }
}